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Mutation in the germline is the ultimate source of genetic variation, but little is known 
about the influence of germline chromatin structure on mutational processes. Using 
ATAC-seq, we profile the open chromatin landscape of human spermatogonia, the 
most proliferative cell-type of the germline, identifying transcription factor binding 
sites (TFBSs) and PRDM9-binding sites, a subset of which will initiate meiotic 
recombination. We observe an increase in rare structural variant (SV) breakpoints at 
PRDM9-bound sites, implicating meiotic recombination in the generation of 
structural variation. Many germline TFBSs, such as NRF1, are also associated with 
increased rates of SV breakpoints, apparently independent of recombination. 
Singleton short insertions (>=5 bp) are highly enriched at TFBSs, particularly at sites 
bound by testis active TFs, and their rates correlate with those of structural variant 
breakpoints. Short insertions often duplicate the TFBS motif, leading to clustering of 
motif sites near regulatory regions in this male-driven evolutionary process. Increased 
mutation loads at germline TFBSs disproportionately affect neural enhancers with 
activity in spermatogonia, potentially altering neurodevelopmental regulatory 
architecture. Local chromatin structure in spermatogonia is thus pervasive in shaping 




Mutation is the ultimate source of genetic variation, and inherited variation must 
invariably arise in the germline. It is well established from cross-species comparisons 




(>10^6 bp) scale across the genome (Wolfe et al. 1989; Hodgkinson and Eyre-Walker 
2011), with early replicating regions subject to reduced rates of mutation. These 
patterns similarly manifest in the rate of human single nucleotide polymorphisms 
(SNPs) (Stamatoyannopoulos et al. 2009). Germline structural variation in the human 
genome is also associated with replication timing, such that copy number variants 
(CNVs) emerging from homologous recombination-based mechanisms are enriched 
in early replicating regions, while CNVs arising from non-homologous mechanisms 
are enriched in late replicating regions (Koren et al. 2012). Local chromatin structure 
also influences the mutation rate. However, finer-scale variation (<1Mb) in the 
germline mutation rate has so far only been related to genomic features derived from 
somatic cells (Gonzalez-Perez et al. 2019) because human germline-derived measures 
of chromatin structure have only recently become available (Guo et al. 2017; Guo et 
al. 2018). Transcription factor binding sites (TFBSs) are particularly prone to point 
mutations in cancer (Kaiser et al. 2016), probably due to interference between TF 
binding and the replication and repair machinery (Reijns et al. 2015; Sabarinathan et 
al. 2016; Afek et al. 2020), but the mutational consequences of binding at these sites 
in the germline is unknown.  
 
During meiosis, homologous recombination may introduce short mutations or render 
genomic regions prone to rearrangements (Pratto et al. 2014; Halldorsson et al. 2019). 
A key player in this process is PRDM9, which binds its cognate sequence motif and 
directs double-strand break (DSB) formation in meiotic prophase (Baudat et al. 2010; 
Myers et al. 2010). In humans, PRDM9 binding site occupancy has only been directly 
assayed in a somatic cell line (Altemose et al. 2017), whereas indirect measures of 




(ssDNA)) in testis (Pratto et al. 2014), and population genetic based measures of 
recombination hotspots (HSs) (Myers et al. 2005; The 1000 Genomes Project 
Consortium 2015). The method ATAC-seq (Buenrostro et al. 2013) reports chromatin 
accessibility and provides a snapshot of all active regulatory regions and occupied 
binding sites in a given tissue. In particular, ATAC-seq footprinting (Sherwood et al. 
2014; Li et al. 2019), when applied to spermatogonia, has the potential to reveal the 
binding of hundreds of TFs, as well as PRDM9, in the male germline. In addition, 
large human genome sequencing projects can be used to reveal patterns of mutation 
rates, by focussing on extremely rare variants (Messer 2009; Carlson et al. 2018; Li 
and Luscombe 2020). Making use of such variant datasets as well as novel ATAC-seq 
data in spermatogonia, we study the mutational landscape at transcription factor 




Spermatogonial regulatory regions are enriched for rare deletion breakpoints 
 
We used ATAC-seq to identify open chromatin sites in FGFR3-positive 
spermatogonial cells isolated from dissociated human testicular samples. FGFR3 is 
most highly expressed in self-renewing spermatogonial stem cells, with low 
expression also being detected in early differentiating spermatogonia (Guo et al. 
2018; Sohni et al. 2019); its expression thus overlaps with the onset of PRDM9 
expression in pre-meiotic spermatogonia (Human Protein Atlas: 
https://www.proteinatlas.org/ENSG00000164256-PRDM9/celltype/testis and 




2018). Open chromatin in FGFR3-positive cells was identified using standard peak 
detection analysis (Methods), and multiple metrics (Supplemental Fig. S1) indicated 
high data quality (Yan et al. 2020). Hierarchical clustering (Ramirez et al. 2016) 
showed that this novel spermatogonial ATAC-seq dataset displays a genome-wide 
distribution of peaks consistent with other spermatogonial derived data, and is distinct 
from ES cell and somatic tissue datasets (Supplemental Fig. S2). 
 
We assessed the enrichments of different classes of sequence variants at 
spermatogonial active sites, including singleton SV breakpoint frequencies as a proxy 
for the mutation rate of such variants. We made use of ultra-rare genomic variants 
from a variety of human sequencing studies: the Deciphering Developmental 
Disorders (DDD) study (Deciphering Developmental Disorders Study 2015; Mcrae et 
al. 2017) of severe and undiagnosed developmental disorders 
(https://www.ddduk.org/), a large collection of variants from an aggregated database 
(gnomAD; http://gnomad.broadinstitute.org/), and de novo variants from trio 
sequencing studies (http://denovo-db.gs.washington.edu/, https://research.mss.ng/, An 
et al. (2018)). Based on the DDD dataset - a combination of high-density arrayCGH 
and exome sequencing (Deciphering Developmental Disorders Study 2015) - we 
identified 6,704 singleton deletion variants among 9,625 DDD probands (carrier 
frequency of ~ 0.002% in the combined dataset) (Supplemental Table S1). 
Permutation analysis demonstrates that DDD singleton breakpoints are enriched at 
spermatogonial ATAC-seq sites, their overlap being > 4-times the expected genome-
wide rate (Supplemental Table S2), and shifted permutation Z-scores reveal that the 
enrichment is specific to the ATAC-seq peaks as opposed to wider genomic regions 




breakpoint coordinates, see Methods) that were present in the DDD consensus dataset 
(Deciphering Developmental Disorders Study 2015) at a frequency of at least 1%, 
representing variants expected to be relatively common in human populations 
(Methods and Supplemental Table S1). These variants show a dip in frequency and 
downward trend near active sites (Figure 1a). However, we note that the overlap 
between common variant breakpoints and ATAC-seq peaks is still ~ 2-fold higher 
than the expected genome-wide rate (p < 10-4). We conclude that singleton deletion 
breakpoints often occur at TFBSs in spermatogonia, suggesting a higher mutational 
input or less accurate repair at these sites compared to neighbouring regions. The 
breakpoints of more common variants are observed less frequently at the same 
binding sites, which may indicate the action of purifying selection in the removal of 
deleterious mutations at these active regulatory sites.  
 Similar trends are also observed for singleton deletion breakpoints from an 
independent large-scale aggregated dataset of human variants (Figure 1e, 1f) from 
whole genome sequence (WGS) analysis (Collins et al. 2020) (Supplemental Table 
S1). We again find a significant enrichment of singleton variant breakpoints at 
ATAC-seq peaks, and this enrichment is not seen for common variants (Figure 1). 
 
Locally elevated mutation at spermatogonial TFBSs 
 
Compared to larger structural variants, such as those (up to megabase sized) deletions 
examined above, indels have been shown to occur at a higher rate of about 6 new 
variants per genome and generation (Besenbacher et al. 2016). Short indels (<= 4 bp) 
are thought to arise due to replication slippage (Levinson and Gutman 1987; 




inaccurate DNA repair after DSBs (Rodgers and McVey 2016). Here, we focus on 
gnomAD singleton indels <= 20 bp as these variants are expected to be well resolved 
using short read sequencing. To enable higher spatial resolution of the mutation 
patterns at ATAC-seq defined accessible chromatin regions, and for the subsequent 
inference of the associated DNA-binding proteins, we identified 706,008 protein 
binding sites using ATAC-seq footprinting analysis (Li et al. 2019) (Methods; 
Supplemental Tables S3 and S4). The rate of singleton 5-20 bp insertions at 
footprinted spermatogonial protein binding sites approximately doubles from 
background expectation and is highly concentrated to within 1 kb of the binding site 
(Figure 2); shifted Z-scores based on genome-wide circular permutations similarly 
show a highly localized spike of insertions around TFBSs (Figure 2). This pattern 
starkly contrasts the localised depletion of common variants of the same mutation 
class at the same binding sites (Figure 2), again implicating a locally elevated 
mutation rate and purifying selection. In fact, most classes of rare mutation (singleton 
SVs, smaller and longer indels, SNPs) are significantly enriched at spermatogonial 
TFBSs (Figure 3), and in the gnomAD dataset, where all singleton classes have been 
ascertained by WGS, the enrichment is strongest for insertions >= 5 bp. We 
confirmed the enrichment of singleton short insertions and SV deletion breakpoints at 
spermatogonial TFBSs, using an independent permutation approach with bedtools 
shuffle (Quinlan and Hall 2010) (Supplemental Methods and Supplemental Table S5). 
In addition to singleton variants from large population samples, we also 
compiled a set of “gold standard” de novo short variants from a range of trio 
sequencing studies (see Methods). The de novo variants show a similar trend to the 
gnomAD singleton variants, with a moderate (~10-60%) increase of mutation rates at 




~130% for insertions of 5-20 bp (Figure 3). These results were confirmed using a set 
of independent positive and negative control sites (Supplemental Fig. S3). We 
conclude that regulatory sites that are active in spermatogonia show unusual parallel 
enrichments for both large SV breakpoints and 5-20 bp insertions, consistent with 
localised DNA damage or error-prone repair.  
 
Germline PRDM9 and NRF1 binding generate hotspots for structural variation  
 
To examine any differences in mutational loads associated with different binding 
factors, we analysed mutational patterns stratified by the binding factors included in 
the JASPAR database (Sandelin et al. 2004). We accounted for redundancy caused by 
multiple factors binding to a single motif by considering 167 motif families 
(Supplemental Table S7). Furthermore, using the reported binding site motif for 
PRDM9 (Myers et al. 2008), we defined 9,778 putative PRDM9-bound sites 
corroborated by evidence for H3K4me3 enrichment in testis (Methods). 
The spermatogonial binding sites of 11% (19/167) of motif families overlapped DDD 
singleton deletion breakpoints more often than expected, and, similarly, 29% (48/167) 
of motif families were significantly enriched for gnomAD singleton deletion 
breakpoints (Bonferroni corrected p = 0.017); no motif family was found to be 
depleted for breakpoints in either dataset (Supplemental Tables S3 and S4), 
suggesting that increased load is a common feature of TFBSs bound by different 
transcription factors in the germline. Similarly, singleton 5-20bp insertions from the 
gnomAD database were found to be significantly enriched at 29% (48/167) of 
families (Bonferroni corrected p = 0.017) and, nominally, 84% (140/167) of families 




family was found to be depleted for these rare variants. Collectively, these results 
suggest that TFBSs active in spermatogonia incur locally elevated burdens of short 
insertions and large structural variants across many different binding motifs. 
 
Certain motif families appear to carry notably higher mutational loads than the 
general disruption seen across all TFBSs. Based on the insertion fold enrichment 
(IFE), i.e. the ratio of the observed to expected numbers of insertions (5-20 bp), 
PRDM9 binding sites are among the most disrupted sites in the genome (IFE = 6.3), 
and this also holds for PRDM9 sites outside known sites of recombination (IFE = 6.7 
for 8,139 PRDM9 sites with a distance of at least 500bp from HSs and ssDNA sites, 
respectively). PRDM9 sites are similarly associated with higher rates of singleton 
deletion breakpoints (Figure 4a, 4c), in line with the roles of PRDM9 during 
recombination, though PRDM9 sites outside known sites of recombination also show 
this trend (observed overlaps with deletion breakpoints = 9; expected = 1; p < 10-4). 
Two other TFBS families, corresponding to NRF1 (Nuclear Respiratory Factor 1; 
IFE=7.0) and HINFP (IFE=6.6) exceed the disruption seen at PRDM9 sites, and 
NRF1 sites are also disrupted at high rates according to DDD and gnomAD 
breakpoint data (Supplemental Tables S3 and S4). Shifted Z-scores for the enrichment 
of short insertions (5-20 bp) at both NRF1 and PRDM9 binding sites are in the top 
four, next to SP/KLF transcription factors (motif families 938 and 992), suggesting 
strong focal enrichments at these sites (Supplemental Tables S5 and S7). NRF1 has 
been shown to be an important testis-expressed gene with meiosis-specific functions 
(Wang et al. 2017; Palmer et al. 2019), but NRF1 binding sites have, to our 
knowledge, not been reported to be foci for genomic instability. We find similar 




spermatogonial samples produced in previous ATAC-seq studies (Guo et al. 2017; 
Guo et al. 2018). Reprocessing these previous datasets identically to our own reveals 
that PRDM9, NRF1 and HINFP sites are again among the top 5 disrupted motif 
families (Supplemental Tables S8 and S9). 
 
Although both PRDM9 and NRF1 binding sites are GC-rich, their modest motif 
similarity suggests that the two factors occupy distinct binding motifs (PWMclus: 
Pearson’s correlation distance r = 0.35 for PRDM9 versus and NRF1) and should not 
converge on the same sites. However, in practice, PRDM9 and NRF1 binding sites 
were often found within the same regulatory regions, such that many (1,199) ATAC-
seq peaks contained both the NRF1 and PRDM9 binding motifs. The disruption of 
motifs within these co-bound peaks was notably higher, with NRF1-motifs being 
disrupted by short insertions 10.8-fold the expected rate (observed: 108; expected: 
10), and PRDM9-motifs 11.2-fold the expected rate (observed: 146; expected: 13) 
when co-occurring with the other factor (p < 10-4 in each case). Similarly, 1,311 
ATAC-seq peaks contained a motif for both CTCF and PRDM9, and CTCF motifs in 
these peaks were more highly disrupted by short insertions (ratio = 6.3; observed: 69; 
expected: 11) compared to all CTCF motifs (Supplemental Table S4), as was PRDM9 
(ratio = 8.2; observed: 115; expected: 14) (p < 10-4 in each case). 
Importantly, the excess of insertions observed at particular motif sites is not a trivial 
consequence of statistical power (i.e. the number of TFBSs in the genome); for 
example, the number of binding sites identified for PRDM9 and NRF1 is fewer than 
many other factors (< 10,000 sites each; Supplemental Tables S3 and S4). 
In general, mutational loads appear to be dependent on the level of chromatin 




ATAC-seq defined regulatory regions, such that regions in the upper quartile of 
accessibility that are also occupied by more than 4 factors incur the highest indel 
loads (Supplemental Fig. S4). The significant positive correlation between the rates of 
binding site disruption via singleton insertions and deletion breakpoints across all 
motif families (Supplemental Fig. S5; Spearman’s R = 0.52, p < 10-5) suggests that the 
two types of damage may be mechanistically linked. In support of this idea, singleton 
short insertions (5-20 bp) and singleton SV deletion breakpoints overlap at the exact 
nucleotide position more often than expected (genome-wide Z-score = 26.31; p < 10-4; 
see also Supplemental Fig. S6). This overlap is unlikely to be due to erroneous variant 
calling in the singleton dataset since we observe similar patterns for common variants 
of the same variant categories (genome-wide Z-score = 62.9, p < 10-4). 
 
Short insertions generate clustered binding sites within regulatory regions 
 
5-20 bp insertions observed at TFBSs frequently occur within only a few nucleotides 
of the binding motifs, whereas other classes of short variants do not show such a 
precisely localized increase (Figure 5 and Supplemental Fig. S7). Despite a moderate 
genome-wide enrichment (Figure 3), the 1-2 bp insertions characteristic of 
polymerase slippage, do not peak in the immediate neighbourhood of TFBSs (Figure 
5 and Supplemental Fig. S7). We examined the consequences of elevated 5-20 bp 
insertion rates at TFBSs using an exhaustive motif search algorithm (Bailey et al. 
2009), which finds overrepresented sequence motifs among a set of input sequences. 
We found that the inserted sequences at a mutated TFBS often contain additional 
copies of the sequence motif corresponding to the original TFBS (Figure 6 and 




duplication events, including events at CTCF, NRF1 and PRDM9 sites. The presence 
of these motif-containing singleton insertions appears to reveal a novel mutational 
mechanism expected to increase the number of binding sites for a binding factor and 
to lead to the expansion of TFBS clusters. CTCF-binding sites are known to occur in 
clusters (Kentepozidou et al. 2020) and are often affected by singleton insertions in 
our dataset (ranked 12th out of 167 motif families, based on the number of insertions 
per TFBS; Supplemental Table S4). We find that spermatognial active sites exhibit 
greater homotypic clustering of TFBS than ATAC-seq defined binding sites from 
somatic tissues (Figure 6). Combined with a positive correlation between homotypic 
motif clustering and insertion rate, this suggests that spermatogonia binding sites are 
progressively accruing motif clusters.  
These unusual patterns of clustered TFBSs at indel breakpoints appear to be specific 
to spermatogonial ATAC-seq peaks, and do not reflect genome-wide trends. Applying 
the MEME-Chip algorithm on 50bp regions flanking singleton insertion and deletion 
breakpoints, we were able to re-discover the sequence motifs of commonly disrupted 
binding sites, including the motifs of PRDM9 and NRF1 (Supplemental Table S10). 
In contrast, genome-wide, the motifs discovered flanking these variants were more 
likely to be simple repeats and other low complexity sequences that did not match 
known TFBS motifs, suggesting that processes other than transcription factor binding 
drive DNA breakage outside of active regulatory sites. 
 






Since many regulatory regions of the genome are active across a variety of cell types 
(Andersson et al. 2014), mutation at TFBSs in spermatogonia might disrupt gene 
regulation in other tissues. The developing brain is of particular interest, given reports 
of increased SV burdens in neurodevelopmental disorders (Girirajan et al. 2011; 
Leppa et al. 2016; Collins et al. 2017). We classified developmentally active human 
brain enhancers (distal regulatory elements) supported by neocortical ATAC-seq data 
(de la Torre-Ubieta et al. 2018) according to whether they were either active (10,888 
brain enhancers) or inactive in the male germline (26,162 brain enhancers). We then 
calculated the odds ratio of a singleton mutation affecting a brain enhancer which is 
also active in spermatogonia, relative to a brain enhancer which is inactive in 
spermatogonia. For DDD singleton deletion breakpoints, the odds ratio was 6.82 
(95% CI = [5.34,8.71]), and for a singleton gnomAD insertion (5-20 bp), it was 4.69 
(95% CI = [4.46,4.93]). This suggests that activity in spermatogonia greatly 
predisposes a brain enhancer to DNA damage, and this damage manifests in 
enhancers that share activity with the male germline (Figure 7). Brain enhancers that 
are shared with spermatogonia are, on average, more accessible in the developing 
brain than those that are inactive in the germline (the median “mean of normalized 
counts” for the two types of brain enhancers were 104.8 and 54.1, respectively; 
Wilcoxon test W = 197340000, p-value < 10-15), suggesting a link between enhancer 
activity, the sharing of enhancers across tissues and propensity to mutation. The 
subset of brain enhancers which overlapped spermatogonial active sites were not 
enriched for specific motifs, and the number of motif sites for each motif family were 




That is, the propensity to mutation does not appear to be driven by an enrichment of 
specific motif families in brain enhancers. 
 
Spermatogonia accessible TFBS motifs incur increased rates of disruption  
 
We cannot exclude a small contribution of the TFBS sequence itself on the 
predisposition to mutation (Kondrashov and Rogozin 2004), but our data suggest that 
TF binding is a major driver of insertion and deletion mutation in the human 
germline. This is supported by the fact that we see an increase of disruption of brain 
enhancers if they are active in spermatogonia (Figure 7) and, more generally, an 
increase in the mutational load for sites that are active across other somatic tissue if 
binding also occurs in the germline (Supplemental Table S11). In addition, control 
motif sites (representing the same TFBS but located outside of ATAC-seq peaks) are 
subject to lower rates of mutation compared to motifs within spermatogonial ATAC-
seq peaks (Figure 6c). Motifs within peaks carry, on average, 73% more mutations 
than their control counterparts, and for the most highly disrupted motifs, the 
discrepancy between active and control motifs is even larger. For example, PRDM9 
motifs are 3.4-fold, HINFP 2.9-fold and NRF1 motifs 2.6-fold more disrupted if they 
are active in spermatogonia, relative to spermatogonia inactive motifs. We note that 
this increase in disruption is likely to be a conservative estimate since some control 
sites may be bound at time points in the germline that our ATAC-seq data cannot 
ascertain. 
Since the X Chromosome spends only one third of its time in males - the sex with the 
higher number of germ cell divisions - a depletion of mutations on the X 




Chromosome to be strongly depleted for short singleton gnomAD insertions (5-20 
bp), with a ratio of X to autosome variants per uniquely mappable site of 0.78 
(Supplemental Table S12). However, we note that, despite the overall reduced rate of 
insertions on the X, ATAC-seq peaks on the X are still subject to increased rates of 
insertions compared to genome-wide expectations, suggesting that the inferred effects 
of protein-binding on mutation are larger than the reduction in mutation due to X-
linkage (38 observed insertions in X-linked ATAC-seq peaks, whereas 11 were 
expected; p < 10-4). 
 
To test which candidate genomic feature most reliably predicts DNA damage, we 
used random forest regression to model the rate of singleton variants within 5 kb 
genomic windows, based on their overlap with spermatogonial TFBSs, ssDNA sites, 
LD-based hotspots, average GC content, mappability, gene density, replication time 
as well as various repeat families (LTRs, SINEs, LINEs and simple repeats). In 
models of genome-wide short insertion rates or deletion breakpoint rates, measures of 
replication timing and GC content were important predictors of mutation load as 
expected (Supplemental Fig. S9). Mappability was an important factor for predicting 
mutation rates genome-wide, perhaps reflecting the association between segmentally 
duplicated (low mappability) regions and rapid structural evolution, or perhaps 
suggesting that a fraction of variants may be erroneously called in the gnomAD 
dataset. (Only regions with high mappability were included in our more detailed 
analyses of TFBSs (Figures 3-7 and Supplemental Fig. S7)). However, 
spermatogonial ATAC-seq derived TFBSs contributed additional predictive power to 
the models, even at the scale of the entire genome. The same TFBSs appear to be 




active brain enhancers (Supplemental Fig. S9). Genome-wide, deletion breakpoints 
and 5-20 bp insertions were enriched in early replicating DNA (Spearman’s rank 
correlation with replication timing: rho = 0.08, p < 10 -15 and rho = 0.07, p < 10-15, 
respectively). In contrast, the presence of repeat elements had almost no impact in 
predicting either short insertion or deletion breakpoint rates (Supplemental Fig. S9). 
We conclude that germline active regulatory sites, through their occupancy by DNA 
binding factors, make a substantial contribution to genome-wide de novo structural 




We have demonstrated enrichments of rare and de novo SV breakpoints at 
spermatogonial regulatory sites defined by ATAC-seq, suggesting that these sites 
suffer high rates of DSBs in the male germline. The same sites show unusual parallel 
enrichments for short variants, and particularly 5-20bp insertions. These loads appear 
to be positively correlated with the levels of chromatin accessibility/nucleosome 
disruption (ATAC-seq peak binding strength) and the number of factors predicted to 
bind within the region. These results have implications for the evolution of binding 
site patterns within regulatory regions, and for disrupted regulation in somatic tissues. 
 
Homotypic clusters of TFBSs are a pervasive feature of both invertebrate and 
vertebrate genomes, and have long been known to be a common feature of human 
promoter and enhancer regions (Gotea et al. 2010). Various adaptive hypotheses have 
been proposed for the presence of such clusters such that they provide functional 




region, and allow cooperative DNA binding of TF molecules (Gotea et al. 2010). 
More recently it has been suggested that homotypic TFBS clusters may also 
contribute to phase separation and the compartmentalisation of the nucleus 
(Kribelbauer et al. 2019). Similarly, the clustered patterns of CTCF sites in the 
genome have been ascribed critical roles in chromatin architecture and regulation, 
particularly at regulatory domain boundaries. However, these boundary regions have 
been shown to exhibit genome instability (Kaiser and Semple 2018) and recurrently 
acquire new CTCF binding sites in dynamically evolving clusters (Kentepozidou et 
al. 2020). The data presented here suggest that binding site clusters may arise solely 
as a selectively neutral consequence of the unusual mutational loads at germline 
TFBSs, with clusters maintained by recurrent DNA damage and mis-repair. 
 
We observe significant enrichments of both large SV breakpoints and small insertions 
together at spermatogonial TFBSs. This parallel enrichment may originate from DNA 
breakage, followed by misrepair, conceivably via a pathway such as non-
allelic homologous recombination (NAHR). It is known that NAHR can create large 
insertions and deletions (Kim et al. 2016), and PRDM9 activity is implicated in 
certain developmental disorders arising via NAHR (McVean 2007; Myers et al. 2008; 
Berg et al. 2010). For example, the locations of PRDM9 binding hotspots coincide 
with recurrent SV breakpoints causing Charcot-Marie-Tooth disease, and Hunter and 
Potocki-Lupski/Smith-Magenis syndromes (Pratto et al. 2014). It is possible that the 
sequence similarity at TFBSs scattered across the genome may make them 
particularly prone to NAHR. However, the sequence similarity between the low copy 
repeat units, known to be involved in NAHR, is usually of the size of several kb (Gu 




also lead to short insertions after DNA breakage, usually in G0 and G1 phases of the 
cell cycle. Indeed, NHEJ is the most common repair pathway of DSBs in mammals 
and it is typically error prone (van Gent et al. 2001; Lieber et al. 2003). During NHEJ, 
double-strand break ends are resected to form single-stranded overhangs, but when 
pairing occurs between the tips of the overhangs, sequences near the breakpoints will 
often be duplicated (Rodgers and McVey 2016). Two previous studies using human–
chimpanzee–macaque multiple alignments have shown that high numbers of short 
insertions have occurred in the human lineage (Kvikstad et al. 2007; Messer and 
Arndt 2007), and both conclude that these insertions preferentially take place in the 
male germline, evidenced by decreased mutation rates on the X Chromosome, with 
similar observations in rodents (Makova et al. 2004).  
 
The data presented here suggest that different DNA-binding proteins differ widely in 
their impact on mutation rates. The two proteins with the largest impacts, NRF1 and 
PRDM9, are both highly expressed in testis, revealing a possible link between the 
expression level of a gene encoding a DNA-binding protein and the propensity for 
breakage or inefficient repair at the sites the protein binds. Incidentally, NRF1 has a 
pLI score of 0.999, indicating that it is extremely loss-of function intolerant and 
crucial for the organism’s functioning (Karczewski et al. 2020). A previous study 
(Montgomery et al. 2013), using 1000 Genomes polymorphism data, failed to find an 
increase in indels at PRDM9 motifs genome-wide. This highlights the importance of 
using ATAC-seq data to confine the search for motifs to germline active sites only, 
combined with singleton variants from large-scale sequencing studies as a more 





Although studies of coding sequences, such as the DDD (Deciphering Developmental 
Disorders Study 2015), have revealed many of the genes disrupted in developmental 
disorders, more than half of cases lack a putatively causal variant (Mcrae et al. 2017), 
stimulating interest in the noncoding remainder of the genome, and particularly 
regulatory regions active in development. Limited sequencing data, covering a 
fraction of human regulatory regions, suggests that de novo mutations are enriched in 
these regions and are therefore likely to contribute to neurodevelopmental disorders at 
some level (Short et al. 2018; Gerrard et al. 2020). However, there appear to be very 
few, if any, individual regulatory elements recurrently mutated across multiple cases 
to cause neurodevelopmental disorders with a dominant mechanism (Short et al. 
2018). The data presented here suggests a potential solution to this paradox, where 
combinations of mutations at multiple regulatory regions may underlie a disease 
phenotype. The frequency of such combinations is expected to be many times higher 
if they involve regulatory regions bound by factors such as NRF1. In such cases, an 




Identification of spermatogonial binding sites 
 
Samples of testicular tissue were obtained from three patients undergoing 
orchiectomy with total processing completed within ~5-7 hours of explant. Tissue 
was obtained after informed consent through the Lothian NRS BioResource, and the 
study was approved by NHS Lothian (Lothian R&D Project Number 2015/0370TB). 




phycoerythrin (PE)-conjugated antibody against the cell surface marker FGFR3 
(FAB766P, clone 136334, R&D systems). Spermatogonial cells were isolated using a 
FACSAria II cell sorter (BD bio- sciences) based on PE fluorescence and cell shape, 
according to Forward/Side Scatter. Isolated cells were subjected to ATAC-seq using 
the protocol and reagents described in (Buenrostro et al. 2013), followed by paired-
end sequencing on Illumina HiSeq 4000 (75 bp read length). We combined reads 
from separate sequencing runs into three biological replicates, based on origin and 
morphological appearance of the FACS sorted cells. Replicate 1: combined 
sequencing runs H.5.1 and H.5.4; a non-cancer patient; large cells, high side scatter; 
58,000 and 42,000 cells, respectively. Replicate 2: combined sequencing runs H.5.2 
and H.5.5; the same non-cancer patient as Replicate 1; large cells; 36,000 and 23,000 
cells, respectively. Replicate 3: combined sequencing runs H.7.3 and H.10.2; normal 
tissue from cancer patients; large cells; 69,000 and 24,000 cells, respectively. Raw 
reads were processed and ATAC-Seq peaks called as described in the Supplemental 
Methods. For the downstream mutation analyses, ATAC-seq peaks from Replicates 1 
and 2 (the non-cancer patient) were merged, creating a single peak set. This dataset 
also formed the basis for the footprinting analysis, which used, as input, the combined 
short sequencing fragments of Replicates 1 and 2, running “rgt-hint footprinting” with 
--atac-seq and --bias-correction, followed by “rgt-motifanalysis matching” with the 
option --remove-strand-duplicates (Li et al. 2019). Input motifs were the 579 position 
weight matrixes (PWMs) of the JASPAR vertebrate database (Sandelin et al. 2004) as 
well as the 13-mer PRDM9 motif “CCNCCNTNNCCNC” (Myers et al. 2010) which 
was also provided as a PWM. The tissue donor for Replicates 1 and 2 was a carrier of 
the most common (European) alleles of PRDM9, which was confirmed by 




this SNP was covered by our ATAC-seq by 10 reads, all of which were “T”. 
Accordingly, we assume that the donor is a carrier of the A and/or B allele of PRDM9 
(both of which bind the same DNA motif), and the search for the 13-mer PRDM9 
motif in this patient’s ATAC-seq data can be used as a proxy for PRDM9 binding in 
European populations. In addition, Replicate 3 was processed in the same way as the 
combined Replicates 1 and 2 and served as a positive control to assess the genome-
wide enrichment of mutations at spermatogonial accessible sites (Supplemental Fig. 
S3). 
 
JASPAR input motifs are often highly similar, resulting in multiple binding proteins 
being identified by the rgt-hint pipeline to bind at the same ATAC-seq footprint; this 
is biologically implausible (since only one protein is likely to occupy a given site), 
and we clustered motifs by similarity, using the default parameters of the PWMclus 
CCAT package (Jiang and Singh 2014). This resulted in a set of 167 motif families of 
similar binding motifs (Supplemental Table S7). Using BEDtools (Quinlan and Hall 
2010), we merged overlapping binding sites that belonged to motifs of the same 
family (thus calling them only once), and we also merged palindromic binding sites 
called on both strands. Since PRDM9 is known to leave a characteristic histone 
methylation mark on bound DNA (Grey et al. 2011; Powers et al. 2016), we 
intersected the PRDM9 motif sites with testis-derived H3K4me3 marks (called in an 
PRDM9 A/B heterozygous individuals) from Pratto et al. (2014). This resulted in a 
stringent set of PRDM9 sites, which were both located in ATAC-seq footprints and 
also carried the H3K4me3 mark in human testis. ATAC-seq-defined PRDM9 sites 
showed moderate overlap with DMC1-bound ssDNA sites (Pratto et al. 2014) as well 




in our experiments are likely to be pre-meiotic: only 10 and 11% of PRDM9 sites 
were within 500 bp of a ssDNA peak and a recombination HS, respectively, whereas 
44% of DMC1-bound sites overlap with LD-defined HSs. However, we find that 
stronger ssDNA peaks are more likely to be near a PRDM9-binding site 
(Supplemental Fig. S10). 
 
Comparisons between ATAC-seq datasets 
 
Using the same procedure as described in the Supplemental Methods, we processed 
raw ATAC-seq reads from previously published datasets in order to call MACS2 
peaks from short sequencing fragments. Datasets included ATAC-seq reads from the 
germinal zone and cortical plate of the developing brain (SRR6208926, SRR6208927, 
SRR6208938, SRR6208943) (de la Torre-Ubieta et al. 2018), ATAC-seq experiments 
of KIT+ spermatogonia (sra accessions SRR7905001 and SRR7905002) (Guo et al. 
2018), SSEA4+ spermatogonia (SRR5099531, SRR5099532, SRR5099533, 
SRR5099534) (Guo et al. 2017) and ESC cells (SRR5099535 and SRR5099536) 
(Guo et al. 2017). Adapter sequences within raw sequencing data were identified 
using bbmerge.sh of bbmap (https://sourceforge.net/projects/bbmap/) and removed 
using cutadapt (Martin 2011), as above. ENCODE ATAC-seq datasets (ENCODE 
Project Consortium 2012; Davis et al. 2018) (Liver: ENCFF628MCV, Ovary: 
ENCFF780JBA, Spleen: ENCFF294ZCT, Testis: ENCFF048IOT, Transverse Colon: 
ENCFF377DAO) were downloaded as BAM files, converted to BEDPE format, and 
short fragments were identified for peak calling. 
 





Large SVs, identified by high-density arrayCGH, or a combination of arrayCGH + 
exome sequencing, were extracted from a cohort of 9,625 DDD patients, using variant 
calling procedures as described in (Deciphering Developmental Disorders Study 
2015). We filtered the DDD variants to only keep variants which fulfilled the 
following criteria: a CNsolidate wscore >= 0.468, a callp < 0.01 and a mean log2 ratio 
of < -0.41 for deletions and 0.36 for duplications; CIFER “false positives” were 
removed.  Singleton variants were identified as being annotated as “novel” by the 
DDD release, only seen once among the DDD patients, and not seen in the dgv 
(MacDonald et al. 2014) and gnomAD V.2 (Collins et al. 2020) structural variant 
datasets (80% reciprocal overlap criterion). Since there are 9,625 patients in the DDD 
dataset, the gnomAD V.2 dataset contains SVs from 10,738 genomes and the dgv 
contains SVs from 29,084 individuals, this puts an upper limit of the frequency of 
carriers of a singleton variant at ~ 0.002%. Breakpoints were identified as the 5’ and 
3’ coordinates of SVs, resulting in 13,406 singleton deletion and 3,406 duplication 
breakpoints; the resolution of the breakpoints was such that the median and mean 
confidence intervals were 300 bp and 12 kb, respectively. Thus, the DDD dataset has 
a lower resolution compared to WGS data, but its advantage is that it does not suffer 
from mapping and variant calling issues associated with the latter (Mahmoud et al. 
2019).  
We further identified 11,962 “common” deletion variants in the DDD dataset, which 
had a minimum variant frequency of 1% in the consensus CNV dataset as described 
by the DDD study (2015), i.e. pooled CNV datasets of Conrad et al. (2010), the 
Genomes Project Consortium (2010), the Wellcome Trust Case Control (2010) and 




common variants using the bedmap options --echo-map --fraction-both 0.8, followed 
by bedops --merge (Neph et al. 2012). The breakpoints of common variants are thus 
the outermost coordinates of all SVs that are collapsed into a given variant. The 
overlap of such “common” breakpoints with ATAC-seq peaks was assessed 
independently of SV allele frequencies, i.e. a group of common SVs contributed two 
breakpoints to the analysis.  
We also identified a set of singleton CNVs called with the Manta algorithm (Chen et 
al. 2016) from the gnomAD V.2 database (Collins et al. 2020) (80% reciprocal 
overlap criterion with gnomAD V.2, dgv and DDD variants), resulting in a set of 
73,063 deletion and 15,419 duplication breakpoints seen in ~ 0.002% of individuals 
but called with a different approach compared to the DDD. Common deletions and 
duplications ( p >= 0.05 ) were also extracted from the gnomAD V.2 dataset; these 
variants had also been called with the Manta algorithm and included 5,954 deletion 
and 1,586 duplication breakpoint sites. 
 
Indels and SNP data 
 
The recently released gnomAD V.3 variants (indels and SNPs) were downloaded 
from https://gnomad.broadinstitute.org/. Only variants that passed all filters were kept 
(filtering using VCFtools --remove-filtered-all) (Danecek et al. 2011). Multiallelic 
variants were split using BCFtools (Danecek et al. 2021), and bcftools norm --
IndelGap 2 was applied to indels, to allow only variants to pass that were separated by 
at least 2 bp. Singleton variants were defined as having an allele count of one, and the 





We subdivided gnomAD indels into singleton insertions and deletions of different 
sizes: 1-2 bp (most commonly arising due to replication slippage) and those 5-20 bp 
(arising due to other mechanisms of DNA instability and within the size range reliably 
detected by short-read sequencing). To speed up simulations and allow for easy 
comparison between categories of variants, all classes of InDels and single nucleotide 
variants were down-sampled to 650,000 variants each. 
 
A total of 854,409 de novo SNPs and indels were compiled from three different 
sources, lifted over to the hg38 assembly using the UCSC liftOver tool as required. 
First, we downloaded variants from http://denovo-db.gs.washington.edu/, including 
only samples from whole genome sequencing studies (Michaelson et al. 2012; Ramu 
et al. 2013; The Genome of the Netherlands Consortium 2014; Besenbacher et al. 
2015; Turner et al. 2016; Yuen et al. 2016; Jonsson et al. 2017; RK et al. 2017; Turner 
et al. 2017; Werling et al. 2018), which included a total of 404,238 variants from 
4,560 samples. Additional samples, which were not already included in the denovo-db 
dataset, were downloaded from the MSSNG database (https://research.mss.ng/), 
version 2019/10/16, which added 2,243 samples and 215,044 de novo mutations. A 
third source of de novo variants came from(An et al. 2018) - 3,805 samples and 




To obtain a genome-wide estimate of enrichment of overlap between genomic 
features (e.g. TFBSs and mutations), we performed circular permutations using the 




function with parameters ntimes=10000, 
randomize.function=circularRandomizeRegions, evaluate.function=numOverlaps, 
genome=hg38_masked, alternative="auto", where hg38_masked = 
getBSgenome("BSgenome.Hsapiens.UCSC.hg38.masked"). This test evaluates the 
number of overlaps observed between two sets of genomic features, given their order 
on the chromosome and the distance between features, i.e. taking their degree of 
clustering into account; Z-score analysis reveals the degree of local enrichment of 
overlaps (Supplemental Methods) . 
For permutations involving SVs, we used the two breakpoints of each SV, and 
assessed the overlap of breakpoints with another feature of interest (i.e. ATAC-seq 
sites), treating each breakpoint separately. 
Circular permutations in regioneR (Gel et al. 2016) were also used assess the mean 
distance between ATAC-seq peaks and deletion breakpoints, for common and 
singleton variants separately. 
 
Brain enhancer data 
 
Active brain enhancers came from de la Torre-Ubieta et al. (2018). Specifically, we 
used the 37,050 brain enhancers which showed differential accessibility in the 
germinal zone versus the cortical plate, reflecting activity in the developing brain (de 
la Torre-Ubieta et al. 2018). Next, we identified brain enhancers that were also active 
during the male germline formation, i.e. overlapping the spermatogonial ATAC-seq 
peaks. To correct for the variable size of the brain active enhancers, we took the 
midpoints of each enhancer plus/minus 500 bp on either side, and intersected these 




classifying brain enhancers as spermatogonial “active” or “inactive”. Next, we 
intersected these two categories of brain enhancers with the DDD breakpoint and 
gnomAD insertion dataset, respectively, to further classify them as “disrupted” by a 
singleton variant or “intact”. An odds ratio was calculated as 
 
OR = (A/(B - A))/(C/(D - C)) 
With confidence intervals  
CI_lower = exp(log(OR) -1.96 * sqrt(1/A + 1/(B-A) + 1/C + 1/(D-C))) 
CI_higher = exp(log(OR) +1.96 * sqrt(1/A + 1/(B-A) + 1/C + 1/(D-C))) 
 
where: 
A = Disrupted, sperm active 
B = All sperm active 
C = Disrupted, sperm inactive 
D = All sperm inactive 
 
To analyse the enrichment of short InDels and SNPs around TFBSs and brain 
enhancers, we only considered genomic regions with unique mappability in >= 95% 
of the region, using the bedmap option --bases-uniq-f (Neph et al. 2012) and the 
mappability file hg38_umap24 (Karimzadeh et al. 2018), converted to bedmap 
format. 
 





To compare the effects of chromatin state on mutation rates, we performed random 
forest regression with 200 trees, modelling the outcome variables “singleton 
breakpoints” and “singleton insertions (5-20 bp)”, from the DDD and gnomAD V.3 
respectively, within 5-kb wide genomic windows.  Predictor variables included 
“spermatogonial TFBS count”, “ssDNA overlap” (from Pratto et al. (2014)), 
“recombination HS overlap” (from The 1000 Genomes Project Consortium (2015)), 
“GC-content”, “Replication timing” (average of Wavelet-smooth signal in 1-kb bins 
of 15 ENCODE tissues, downloaded  from 
http://hgdownload.soe.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeUwRepliSeq
/), “Gene density”, “Mappability” (proportion of sites in each window with an 
umap24 score of 1), and the overlap with “LTRs”, “SINEs”, “LINEs” and “Simple 
Repeats” (downloaded from the Table Browser at https://genome.ucsc.edu/).  
In a smaller model, we subset the dataset to only include 5-kb bins that also overlap 
active brain enhancers (de la Torre-Ubieta et al. 2018), then ran the random forest 
regression model to predict mutation rates within genomic regions that contain active 
brain enhancers. 
 
Motif discovery in singleton insertion sites 
 
In order to find sequence motifs within the 5-20 bp singleton insertion sites from 
gnomAD V.3, without prior assumptions, we extracted the FASTA sequence for 
insertions that fell within 10 bp of the top 10 disrupted motif families (motif families 
992, 193, 796, 907, 579, 825, 984, 171, 991). We ran the MEME 4.11 motif discovery 




allowed us to compare the sequence motif of the disrupted TFBSs to any recurrent 
motif found within the inserted sequences. 
 
Control Motif sites 
 
Using default search criteria, the FIMO algorithm (Grant et al. 2011) was run on the 
repeat masked hg38 genome sequence (hg38.fa.masked, downloaded from  
https://genome.ucsc.edu/ in March 2020), searching the whole genome for the 579 
input JASPAR motifs and the 13-mer PRDM9 motif. As with active binding sites, 
motif matches belonging to the same motif family were merged and reported as a 
single motif match per family, and only regions with unique umap24 mappabilities for 
>= 95% of sites were kept; motifs that overlapped with spermatogonial ATAC-seq 
peaks were excluded. Next, these “control” motif sites were down-sampled to 10,000 
per motif family (using bedtools sample (Quinlan and Hall 2010)); circular 
permutations were performed to compare the observed to expected overlap of the 
control motif sites (plus/minus 10 bp) with the gnomAD singleton insertions of 5-20 
bp.  
 
The FIMO predicted control sites were also used to assess the degree of “clustering” 
of motifs at spermatogonia active sites. For this purpose, we intersected the FIMO 
motifs with a) spermatogonial ATAC-seq sites and b) ENCODE Master regulatory 
sites downloaded from https://genome.ucsc.edu/ (DNase I hypersensitivity derived 
from assays in 95 cell types). For each of the 167 motif families, we calculated the 
median distance (in basepairs) from a motif located within the active regulatory 




median distance between motif sites (ENCODE/spermatogonia) was larger than one if 
motifs at spermatogonial sites were, on average, closer to each other than motifs near 
ENCODE sites, and we used this ratio as a measure of motif clustering. When 
correlating the IFE with the degree of motif clustering (Figure 6), we thus largely 
correct for base compositional biases near active sites (which impact mutation rates – 
Supplemental Fig. S9) as well as the effects of historical selection on the clustering of 
motifs near genes, i.e. shorter inter-motif distances in spermatogonia indicate that 
these sites have specifically high levels of motif density in spermatogonia, beyond the 




Raw sequencing data generated in this study have been submitted to the European 
Genome-phenome Archive (EGA) (accession number EGAS00001005366); ATAC-
seq peak files are available as Supplemental Data and at Edinburgh DataShare 
(https://doi.org/10.7488/ds/3053).  
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Figure 1: Locally elevated structural variation rates at spermatogonial 
regulatory sites. SV breakpoint count (a, b) and circular permutation shifted Z-scores 
(c, d) of deletion breakpoints in the DDD cohort, centred around the midpoints of 
spermatogonial ATAC-seq peaks. “Singletons” are breakpoints of deletions with a 
frequency of ~ 0.002% across population samples; “common” variants are seen at a 
frequency of at least 1% in the DDD consensus dataset (see main text); permutation 
p-values indicate significant enrichment for both types of variants at ATAC-seq peaks 
(p < 10-5 in each case) (e, f) Circular permutation shifted Z-scores of gnomAD 
deletion breakpoints, centred around spermatogonial ATAC-seq peaks. “Singletons” 
are breakpoints of deletions with a frequency of ~ 0.002% across population samples; 
“common” variants are seen at a frequency of at least 5% in the gnomAD V.2 dataset. 
Permutation p-values indicate significant enrichment for singleton breakpoints (p < 
10-5), and a significant depletion for common variants (p < 0.01). 
Figure 2: Increased rates of short insertions focussed on spermatogonial binding 
sites. Insertion count (a, b) and Shifted Z-scores (d, e) of gnomAD singleton and 
common insertions (5-20 bp), centred around spermatogonial TFBSs. Singletons are 
seen only once in the gnomAD V.3 dataset (allele frequency <= 0.001%) and are 
significantly enriched at binding sites (p < 10-4); common variants have an allele 
frequency of at least 5% within gnomAD V.3 and are significantly depleted at binding 
sites (p < 10-4). 
Figure 3: Parallel enrichments of short variants and SV breakpoints at 
spermatogonial binding sites. Circular permutation results are based on 10,000 




axis shows the ratio of observed over expected variant counts. Mutation categories 
with significant enrichment are indicated by asterisks (*** indicating p < 0.001). The 
type of variant tested and the total number of observed variants overlapping 
spermatogonial TFBSs are indicated below each bar. 
Figure 4: Binding factors associated with the highest rates of mutation at 
spermatogonial binding sites. Plots are centred on the binding sites of a given motif 
family inside ATAC-seq footprints. (a) Singleton and (b) common deletion 
breakpoints in the DDD cohort; singletons are breakpoints of deletions with a 
frequency of ~ 0.002% across population samples; common variants are seen at a 
frequency of at least 1% in the DDD consensus dataset. (c) Singleton and (d) common 
insertions (5-20 bp) in the gnomAD dataset. Singletons are seen only once in 
gnomAD V.3 (allele frequency <= 0.001%), and common variants have an allele 
frequency of at least 5% within gnomAD V.3. Only 10 kb regions around TFBSs with 
>=95% unique mappability (umap24 scores) were included. The top 5 disrupted 
motifs are shown, listed in order of enrichment of singleton variants in the circular 
permutations (all enrichments of singletons are associated with p-values < 10-4). 
Figure 5: Elevated singleton insertion rates at PRDM9 and NRF1 binding sites 
contrast with other short variant classes. All gnomAD variants have been down-
sampled to a total of 650,000 variants per analysis, making the Y axes directly 
comparable; individual bins are 5 bp in size. Only regions around TFBSs with >=95% 
unique mappability (umap24 scores) were included. 
Figure 6: Insertions at spermatogonial TFBSs generate motif clusters in the 
genome. a) JASPAR database sequence motifs identified in the footprints of 
spermatogonial ATAC-seq peaks (left) and the motifs identified in the singleton 




MEME to construct the motif are shown on the right. b) For each motif family, we 
plot the insertion fold enrichment (IFE) on the X axis and the degree of 
spermatogonial motif clustering on the Y axis; the least square regression line is 
indicated in blue. Motif clustering is measured as the distance to the nearest motif at 
spermatogonial active sites, relative to the distance for motifs at ENCODE active 
sites. c) The insertion fold enrichment (IFE) is contrasted between FIMO control 
motif sites (left) and spermatogonial active motif sites (right); the Wilcoxon Test was 
performed to compare the IFE at the two classes of sites. 
Figure 7: Neural enhancers with activity in spermatogonia suffer elevated mutation 
rates. a) Singleton DDD deletion breakpoint and b) singleton gnomAD insertion (5-
20 bp) count around brain active enhancers. Enhancers were classified as being also 
active in spermatogonia (red) or inactive in spermatogonia (blue). Plotted is the 
average number of variants per brain enhancer - in 5 kb windows or 100 bp windows, 
respectively. In b, only 10 kb regions around enhancers with >=95% unique 
mappability (umap24 scores) were included (3,409 brain enhancers that are inactive 
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